Sinqi Ophthalmic Medications is a state-level high-tech company specializing in the R & D, production and sales of ophthalmic medications. The main product of the company is prescription ophthalmic drugs. The company went public on the Shenzhen Stock Exchange GEM (Stock Code: 300573) on December 8, 2016.

Investor Hotline: 024-22503989

Welcome to follow the Wechat account of Sinqi Investor Relations for the latest developments in the company

You can also contact us via stock@sinqi.com